EXAS
Price
$53.57
Change
-$0.11 (-0.20%)
Updated
Sep 26 closing price
Capitalization
10.14B
31 days until earnings call
RVTY
Price
$84.06
Change
+$1.02 (+1.23%)
Updated
Sep 26 closing price
Capitalization
9.76B
37 days until earnings call
Interact to see
Advertisement

EXAS vs RVTY

Header iconEXAS vs RVTY Comparison
Open Charts EXAS vs RVTYBanner chart's image
Exact Sciences
Price$53.57
Change-$0.11 (-0.20%)
Volume$2.25M
Capitalization10.14B
Revvity
Price$84.06
Change+$1.02 (+1.23%)
Volume$915.34K
Capitalization9.76B
EXAS vs RVTY Comparison Chart in %
Loading...
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXAS vs. RVTY commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXAS is a Buy and RVTY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (EXAS: $53.57 vs. RVTY: $84.06)
Brand notoriety: EXAS: Notable vs. RVTY: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EXAS: 70% vs. RVTY: 69%
Market capitalization -- EXAS: $10.14B vs. RVTY: $9.76B
EXAS [@Medical Specialties] is valued at $10.14B. RVTY’s [@Medical Specialties] market capitalization is $9.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXAS’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 1 green FA rating(s).

  • EXAS’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 1 green, 4 red.
According to our system of comparison, EXAS is a better buy in the long-term than RVTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXAS’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • EXAS’s TA Score: 5 bullish, 5 bearish.
  • RVTY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RVTY is a better buy in the short-term than EXAS.

Price Growth

EXAS (@Medical Specialties) experienced а +0.47% price change this week, while RVTY (@Medical Specialties) price change was -3.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.53%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +24.99%.

Reported Earning Dates

EXAS is expected to report earnings on Oct 29, 2025.

RVTY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+1.53% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXAS($10.1B) and RVTY($9.76B) have the same market capitalization . EXAS YTD gains are higher at: -4.663 vs. RVTY (-24.528). RVTY has higher annual earnings (EBITDA): 822M vs. EXAS (-758.48M). RVTY has more cash in the bank: 992M vs. EXAS (858M). EXAS has less debt than RVTY: EXAS (2.52B) vs RVTY (3.38B). EXAS (2.94B) and RVTY (2.8B) have equivalent revenues.
EXASRVTYEXAS / RVTY
Capitalization10.1B9.76B104%
EBITDA-758.48M822M-92%
Gain YTD-4.663-24.52819%
P/E RatioN/A36.55-
Revenue2.94B2.8B105%
Total Cash858M992M86%
Total Debt2.52B3.38B75%
FUNDAMENTALS RATINGS
EXAS vs RVTY: Fundamental Ratings
EXAS
RVTY
OUTLOOK RATING
1..100
9265
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9787
PRICE GROWTH RATING
1..100
4964
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (21) in the Medical Specialties industry is in the same range as EXAS (44) in the Biotechnology industry. This means that RVTY’s stock grew similarly to EXAS’s over the last 12 months.

RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EXAS (100) in the Biotechnology industry. This means that RVTY’s stock grew similarly to EXAS’s over the last 12 months.

RVTY's SMR Rating (87) in the Medical Specialties industry is in the same range as EXAS (97) in the Biotechnology industry. This means that RVTY’s stock grew similarly to EXAS’s over the last 12 months.

EXAS's Price Growth Rating (49) in the Biotechnology industry is in the same range as RVTY (64) in the Medical Specialties industry. This means that EXAS’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's P/E Growth Rating (95) in the Medical Specialties industry is in the same range as EXAS (100) in the Biotechnology industry. This means that RVTY’s stock grew similarly to EXAS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EXASRVTY
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 4 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSYY8.420.22
+2.63%
GraniteShares YieldBOOST TSLA ETF
IAI175.261.42
+0.82%
iShares US Broker-Dealers&Secs Exchs ETF
HOCT23.950.01
+0.04%
Innovator Premium Income 9 Buf ETF - Oct
MINV36.47-0.50
-1.34%
Matthews Asia Innovators Active ETF
BGH15.66-0.53
-3.27%
Barings Global Short Duration High Yield Fund

EXAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with ILMN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
-0.20%
ILMN - EXAS
36%
Loosely correlated
-0.54%
RVTY - EXAS
34%
Loosely correlated
+1.23%
A - EXAS
34%
Loosely correlated
+1.23%
XRAY - EXAS
33%
Poorly correlated
+2.38%
VCYT - EXAS
32%
Poorly correlated
+1.89%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with MTD. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
+1.23%
MTD - RVTY
81%
Closely correlated
-0.42%
A - RVTY
79%
Closely correlated
+1.23%
TMO - RVTY
77%
Closely correlated
+1.09%
WAT - RVTY
74%
Closely correlated
+1.36%
DHR - RVTY
72%
Closely correlated
+2.04%
More